US Approves Alzheimer’s Drug That Modestly Slows Disease
WASHINGTON (AP) — U.S. health officials on Friday approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh. The drug, Leqembi, is the…